Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-21-013814

Chief Financial Officer acquired 29,213 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Saik Andrew · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-22 Grant or award : show line 1 in the form +29,213 114,213 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-22 Grant or award : show line 2 in the form Stock Options +68,162 68,162 D
Loading xslF345X03/doc4.xml…